169 related articles for article (PubMed ID: 25257660)
1. Measures to quantify the abuse of prescription opioids: a review of data sources and metrics.
Secora AM; Dormitzer CM; Staffa JA; Dal Pan GJ
Pharmacoepidemiol Drug Saf; 2014 Dec; 23(12):1227-37. PubMed ID: 25257660
[TBL] [Abstract][Full Text] [Related]
2. Drug availability adjustments in population-based studies of prescription opioid abuse.
Secora A; Trinidad JP; Zhang R; Gill R; Dal Pan G
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):180-191. PubMed ID: 28000295
[TBL] [Abstract][Full Text] [Related]
3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
Manchikanti L; Singh A
Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
[TBL] [Abstract][Full Text] [Related]
5. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
[TBL] [Abstract][Full Text] [Related]
6. Do prescription monitoring programs impact state trends in opioid abuse/misuse?
Reifler LM; Droz D; Bailey JE; Schnoll SH; Fant R; Dart RC; Bucher Bartelson B
Pain Med; 2012 Mar; 13(3):434-42. PubMed ID: 22299725
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective.
Manchikanti L; Fellows B; Ailinani H; Pampati V
Pain Physician; 2010; 13(5):401-35. PubMed ID: 20859312
[TBL] [Abstract][Full Text] [Related]
8. Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France.
Pauly V; Pradel V; Pourcel L; Nordmann S; Frauger E; Lapeyre-Mestre M; Micallef J; Thirion X
Drug Alcohol Depend; 2012 Nov; 126(1-2):13-20. PubMed ID: 22475815
[TBL] [Abstract][Full Text] [Related]
9. The burden of the nonmedical use of prescription opioid analgesics.
Gilson AM; Kreis PG
Pain Med; 2009 Jul; 10 Suppl 2():S89-100. PubMed ID: 19691688
[TBL] [Abstract][Full Text] [Related]
10. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
[TBL] [Abstract][Full Text] [Related]
11. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
[TBL] [Abstract][Full Text] [Related]
12. Tamper-resistant opioid formulations in the treatment of acute pain.
Passik SD
Adv Ther; 2014 Mar; 31(3):264-75. PubMed ID: 24526323
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the abuse of tapentadol immediate release: the first 24 months.
Dart RC; Cicero TJ; Surratt HL; Rosenblum A; Bartelson BB; Adams EH
J Opioid Manag; 2012; 8(6):395-402. PubMed ID: 23264317
[TBL] [Abstract][Full Text] [Related]
14. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment.
Inciardi JA; Surratt HL; Cicero TJ; Beard RA
Pain Med; 2009 Apr; 10(3):537-48. PubMed ID: 19416440
[TBL] [Abstract][Full Text] [Related]
15. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
[TBL] [Abstract][Full Text] [Related]
16. Assessment of prescription opioid intentional exposures across the rural-urban continuum in the United States using both population and drug availability rates.
Le Lait MC; Martinez EM; Severtson SG; Lavery SA; Bucher-Bartelson B; Dart RC
Pharmacoepidemiol Drug Saf; 2014 Dec; 23(12):1334-7. PubMed ID: 24899151
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
Atluri S; Sudarshan G; Manchikanti L
Pain Physician; 2014; 17(2):E119-28. PubMed ID: 24658483
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
[TBL] [Abstract][Full Text] [Related]
19. The iatrogenic epidemic of prescription drug abuse: county-level determinants of opioid availability and abuse.
Wright ER; Kooreman HE; Greene MS; Chambers RA; Banerjee A; Wilson J
Drug Alcohol Depend; 2014 May; 138():209-15. PubMed ID: 24679840
[TBL] [Abstract][Full Text] [Related]
20. Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits.
Davis JM; Severtson SG; Bucher-Bartelson B; Dart RC
Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):18-25. PubMed ID: 24130046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
